Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality business Quality Strong, Valuation Expensive, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #25 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 10 Mar 2026 | Vijay Gosar | Employee / designated person | Sell | 0 | ₹0 |
| 20 Feb 2026 | MEHUL MANSUKHBHAI KOLADIA | Employee / designated person | Sell | 0 | ₹0 |
| 30 Dec 2025 | Bhavesh Mansukhbhai Kotadiya | Employee / designated person | Buy | 0 | ₹0 |
| 20 May 2025 | NARESHKUMAR RAMJIBHAI PATEL | Promoter | Sell | 0 | ₹0 |
| 20 May 2025 | Chetankumar Chhaganlal Vaghasia | Promoter | Sell | 0 | ₹0 |
| 6 Jan 2025 | RAM MOHAN LOKHANDE | Director | Buy | 0 | ₹0 |
| 6 Jan 2025 | RAM MOHAN LOKHANDE | Director | Sell | 0 | ₹0 |
| 13 Nov 2024 | Chetankumar Chhaganlal Vaghasia | Promoter | Buy | 0 | ₹0 |
| 13 Nov 2024 | Chhagan Ramjibhai Vaghasia | Promoter group | Sell | 0 | ₹0 |
| 8 Nov 2024 | Bhanuben Chhaganlal Vaghasia | Promoter group | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 24 Nov 2025 | ISHARES CORE MSCI EMERGING MARKETS ETF | Bulk | Buy | 530,290 | 1852.1200 | NSE |
| 1 Aug 2024 | PLUTUS WEALTH MANAGEMENT LLP | Bulk | Sell | 1,000,000 | 1350.0000 | BSE |
| 1 Aug 2024 | SBI MUTUAL FUND | Bulk | Buy | 1,162,265 | 1350.0000 | BSE |
| 29 Aug 2023 | MORGAN STANLEY ASIA SINGAPORE PTE NON ODI | Bulk | Buy | 621,898 | 1250.0000 | BSE |
| 29 Aug 2023 | GIRISHKUMAR LIMBABHAI CHOVATIA | Bulk | Sell | 625,000 | 1250.3900 | BSE |
| 19 Jun 2023 | GIRISHKUMAR LIMBABHAI CHOVATIA | Bulk | Sell | 360,000 | 1265.0000 | BSE |
| 13 Sep 2022 | SURABHI YASH SHAH | Block | Sell | 98,000 | 1037.2500 | BSE |
| 13 Sep 2022 | SMALL CAP WORLD FUND INC | Block | Buy | 98,000 | 1037.2500 | BSE |
| 13 Sep 2022 | VIRENDRA NATH MISHRA | Block | Sell | 128,420 | 1037.2500 | BSE |
| 13 Sep 2022 | PLUTUS WEALTH MANAGEMENT LLP | Block | Buy | 128,420 | 1037.2500 | BSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 17 Sep 2026 | Dividend - Rs 2.50 Per Share | 2.5000 | 17 Sep 2026 |
| 18 Sep 2025 | Dividend - Rs 1.50 Per Share | 1.5000 | 18 Sep 2025 |
| 13 Sep 2024 | Dividend - Rs 3 Per Share | 3.0000 | 13 Sep 2024 |
| 18 Sep 2023 | Dividend - Rs 3 Per Share | 3.0000 | 18 Sep 2023 |
| 29 Jul 2022 | Annual General Meeting/Dividend - Rs 3 Per Share | 3.0000 | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 25 Apr 2025 | SPLIT | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 5/- Per Share |
| — | NAME_CHANGE | Name changed from Ami Organics Limited to ACUTAAS CHEMICALS LIMITED |
| 13 Sep 2024 | OTHER | Annual General Meeting |
| 18 Sep 2023 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 24 Jul 2026 | Financial Results | Yes |
| 30 Apr 2026 | Financial Results/Dividend | Yes |
| 28 Jan 2026 | Financial Results | Yes |
| 17 Oct 2025 | Financial Results | Yes |
| 30 Jul 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
